Objective Circular RNAs (circRNAs) have been discovered as potential
biomarkers for diabetic nephropathy (DN). In this study, the potential roles of
circADAM9 in high glucose (HG)-induced cell injury of human mesangial cells
(HMCs) were investigated, and the underlying mechanism was elucidated.
Methods DN cell model in vitro was simulated by HG treatment of
HMCs. Endogenous expressions of circADAM9, miR-545-3p, and ubiquitin-specific
protease 15 (USP15) were determined by real-time polymerase chain reaction. Cell
proliferation and migration were evaluated using Cell Counting Kit-8 and wound
healing assays. The inflammatory response was assessed by enzyme-linked
immunosorbent assay. Oxidative stress was examined using commercially available
kits. Dual-luciferase reporter and RNA pull-down assays were conducted to
confirm the interaction among circADAM9, miR-545-3p, and USP15.
Results CircADAM9 was upregulated in DN samples and HG-treated HMCs, while
its downregulation inhibited cell proliferation, inflammation, fibrosis, and
oxidative stress. Further investigation revealed that circADAM9 exerted this
influence by targeting the miR-545-3p/USP15 axis, thereby regulating the
KELCH-like ECh-associated protein 1/nuclear factor erythroid 2 related
factor 2 (Keap1/Nrf2) pathway. MiR-545-3p knockdown or USP15
overexpression reversed the effect of circADAM9 silencing in HG-induced
HMCs.
Conclusion These results indicate that the
circADAM9/miR-545-3p/USP15/Keap1/Nrf2 signaling
axis is critical for HG-induced cell injury in HMCs and might represent a novel
therapeutic target for DN treatment.